Open AccessMUTUAL EFFECTS OF DIABETES, OBESITY AND SARS-COV-2
Author(s) -
Л. В. Никонова,
S. V. Tishkovskiy,
О. Н. Мартинкевич,
O. Shidlovskaya
Publication year - 2021
Publication title -
žurnal grodnenskogo gosudarstvennogo medicinskogo universiteta
Language(s) - English
Resource type - Journals
eISSN - 2413-0109
pISSN - 2221-8785
DOI - 10.25298/2221-8785-2021-19-3-263-269
Subject(s) - diabetes mellitus , medicine , obesity , outbreak , intensive care medicine , risk factor , pandemic , concomitant , covid-19 , disease , endocrinology , infectious disease (medical specialty) , virology
Since the first outbreak of SARS-Cov-2 in China, much attention has been paid by the medical community to people with diabetes, as it is well known that diabetes increases the risk of developing various infectious diseases. The reason for this is multifactorial: age, gender, ethnicity, concomitant diseases such as hypertension and cardiovascular diseases, obesity, as well as pro-inflammatory and procoagulatory conditions – all these factors contribute to a more severe course of SARS-Cov-2 in patients with diabetes mellitus. Moreover, severe SARS-Cov-2 infection itself may be a worsening factor for people with diabetes, as it can cause acute metabolic complications through direct negative effects on beta-cell function. This review is intended to provide a systematic assessment of potential prognostic factors and mutual effects in patients with diabetes mellitus, obesity and SARS-Cov-2.